ArticleBMJ open2022

Restoring mortality data in the FOURIER cardiovascular outcomes trial of evolocumab in patients with cardiovascular disease: a reanalysis based on regulatory data.

Juan Erviti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.